MedPath

Metabolic Profiling of Type 1 Diabetes Mellitus in Children and Adolescents

Completed
Conditions
Type1diabetes
Interventions
Other: Blood sampling
Registration Number
NCT03014908
Lead Sponsor
Hasselt University
Brief Summary

The aim of this study was to look for discriminating variation in the concentrations of small-molecule metabolites in the plasma of T1DM children compared with non-diabetic matched controls using proton nuclear magnetic resonance (1H-NMR)-based metabolomics.

Detailed Description

Type 1 diabetes mellitus (T1DM) is one of the most common pediatric diseases and its incidence is rising in many countries. Recently, it has been shown that metabolites other than glucose play an important role in insulin deficiency and the development of diabetes. The aim of this study was to look for discriminating variation in the concentrations of small-molecule metabolites in the plasma of T1DM children compared with non-diabetic matched controls using proton nuclear magnetic resonance (1H-NMR)-based metabolomics.

This cross-sectional study was set-up to examine the metabolic profile in fasting plasma samples from 7 T1DM children and 7 non-diabetic controls aged 8 to 18 years, and matched for gender, age and BMI. The obtained plasma 1H-NMR spectra were rationally divided into 110 integration regions, representing the metabolic phenotype. These integration regions reflect the relative metabolite concentrations and were used as statistical variables to construct (train) a classification model in discriminating between T1DM patients and controls.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • aged between 8 and 18
  • normal-weight according to the International Obesity Task Force (IOTF) BMI criteria
  • fasted for at least 8 hours.
Exclusion Criteria
  • lipid-lowering drugs or other medication

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
NMR-T1DMBlood samplingtype 1 diabetic children and adolescents
NMR-CBlood samplingnon-diabetic children and adolescents
Primary Outcome Measures
NameTimeMethod
Metabolic phenotype of type 1 diabetes mellitus10 months

Significant metabolic changes in blood plasma of type 1 diabetic patients compared with control subjects

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hasselt University

🇧🇪

Hasselt, Limburg, Belgium

© Copyright 2025. All Rights Reserved by MedPath